Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | HTR1D | P28221 | 5/20 | 0.65 |
| ▸ | HTR1B | P28222 | 5/20 | 0.65 |
| ▸ | DRD2 | P14416 | 2/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ly-293284 SCHEMBL6902000 | 1.00 | HTR1A (1.00) | HTR1AHTR1DHTR1BDRD2 | |
| Ly-293284 SCHEMBL7204055 | 1.00 | HTR1A (1.00) | HTR1AHTR1DHTR1BDRD2 | |
| SCHEMBL9412130 | 0.91 | HTR1A (0.83) | HTR1AHTR1DHTR1BDRD2 | |
| SCHEMBL8889776 | 0.91 | HTR1A (0.83) | HTR1AHTR1DHTR1BDRD2 | |
| SCHEMBL6364891 | 0.90 | HTR1A (0.81) | HTR1AHTR1DHTR1BDRD2 | |
| SCHEMBL6765275 | 0.90 | HTR1A (0.81) | HTR1AHTR1DHTR1BDRD2 | |
| SCHEMBL7208944 | 0.90 | HTR1A (0.81) | HTR1AHTR1DHTR1BDRD2 | |
| SCHEMBL8983347 | 0.90 | HTR1A (0.81) | HTR1AHTR1DHTR1BDRD2 | |
| Acetic Acid SCHEMBL7513634 | 0.89 | HTR1A (0.80) | HTR1AHTR1DHTR1BDRD2 | |
| SCHEMBL7516908 | 0.89 | HTR1A (0.80) | HTR1AHTR1DHTR1BDRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023212244-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| EP-3953000-A1 | CELL MEMBRANE PERMEABILITY RESTORING THERAPY | Shine, Ian Basil (US) | 2022-02-16 | — | — | EP | claimed |
| EP-0471576-B1 | 6-substituted-tetrahydrobenz[cd]indoles | LILLY CO ELI (US) | 2003-03-12 | — | — | EP | claimed |
| US-5292766-A | Method for improving primary memory and/or learning | ELI LILLY AND COMPANY (US) | 1994-03-08 | — | — | US | claimed |
| EP-0565274-A1 | 5-Ht1A agonists for improving primary memory and/or learning | ELI LILLY AND COMPANY (US) | 1993-10-13 | — | — | EP | claimed |
| US-5229409-A | Antidepressant, tranquilizer | ELI LILLY AND COMPANY (US) | 1993-07-20 | — | — | US | claimed |
| JP-4230663-A | — | — | None | — | — | JP | disclosed |
| WO-2023212244-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| EP-0471576-B1 | 6-substituted-tetrahydrobenz[cd]indoles | LILLY CO ELI (US) | 2003-03-12 | — | — | EP | disclosed |
| US-5292766-A | Method for improving primary memory and/or learning | ELI LILLY AND COMPANY (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0565274-A1 | 5-Ht1A agonists for improving primary memory and/or learning | ELI LILLY AND COMPANY (US) | 1993-10-13 | — | — | EP | disclosed |
| US-5229409-A | Antidepressant, tranquilizer | ELI LILLY AND COMPANY (US) | 1993-07-20 | — | — | US | disclosed |
| JP-H04230663-A | 6-SUBSTITUTED TETRAHYDROBENZ(C,D)INDOLE | ELI LILLY & CO | 1992-08-19 | — | — | JP | disclosed |